Why Ozone?
The Primary Reason is Oxygen Utilization
Oxygen is your most critical nutrient
But it’s not just what you take in, it’s what you utilize (how much & how well).
The difference between your cells at 20 and your cells at 70 is the efficiency at which you utilize oxygen
The key to the treatment and prevention of disease & disease process is optimum oxygen utilization
Decreased oxygen utilization happens locally and systemically.
Aging and the diseases of aging are caused primarily by decreased oxygen utilization.
This decrease leads to the excessive free radical production that produces the pathology that results in organ breakdown and degenerative disease.
Decreased oxygen utilization is caused by both pre-mitochondrial and mitochondrial factors.
Decreased oxygen utilization exerts its effects by causing a decrease in the NAD/NADH ratio inside the mitochondria.
Ozone therapy is effective for so many diseases including the infirmaties of aging because it normalizes this ratio.
Oxygen works through NAD and ATP (and to a lesser degree NADP and FAD). These “oxygen intermediates” are the bottom line for all cellular function.
The Secondary Reason is inactivation of dangerous microbes
Inactivation of bacteria, viruses, fungi, yeast and protozoa: Ozone therapy disrupts the integrity of the bacterial cell envelope through oxidation of the phospholipids and lipoproteins. In fungi, O3 inhibits cell growth at certain stages. With viruses, the O3 damages the viral capsid and upsets the reproductive cycle by disrupting the virus-to-cell contact with peroxidation. The weak enzyme coatings on cells which make them vulnerable to invasion by viruses make them susceptible to oxidation and elimination from the body, which then replaces them with healthy cells. STUDY, 1, 2, 3, 4, 5, 6, 7, 8, 9
The third reason is circulation enhancement
In circulatory disease, a clumping of red blood cells hinders blood flow through the small capillaries and decreases oxygen absorption due to reduced surface area. Ozone reduces or eliminates clumping and red cell flexibility is restored, along with oxygen carrying ability. Oxygenation of the tissues increases as the arterial partial pressure increases and viscosity decreases. Ozone also oxidizes the plaque in arteries, allowing the removal of the breakdown products, unclogging the blood vessels.
The fourth reason is activation of the immune system
Ozone administered at a concentration of between 30 and 55 μg/cc causes the greatest increase in the production of interferon and the greatest output of tumor necrosis factor and interleukin-2. The production of interleukin-2 launches an entire cascade of subsequent immunological reactions.
Varanasi SS, Francis RM, et al. Mitochondrial DNA deletion associated oxidative stress and severe male osteoporosis. Osteoporos Int. 1999;10(2):143-9.
Viebahn-Hänsler R. The use of ozone in medicine: Mechanisms of action. Munich. 2003. May 23-25, [cited in 2003]
Bocci V, Paulesu L. Studies on the biological effects of ozone 1: Induction of interferon on human leucocytes. Haematologica. 1990;75:510–15.
Liang FQ, Godley BF. Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration. Exp Eye Res. 2003 Apr;76(4):397-403.
Verrazzo G., Coppola L., Luongo C., Sammartino A., Giunta R., Grassia A., Ragone R., Tirelli A. Hyperbaric oxygen, oxygen-ozone therapy, and rheologic parameters of blood in patients with peripheral occlusive arterial disease. Undersea Hyperbar. Med. J. Undersea Hyperbar. Med. Soc. Inc. 1995;22:17–22.
Patwari P, Lee RT. Thioredoxins, mitochondria, and hypertension. Am J Pathol. 2007 Mar;170(3):805-8.
Eerola E, Pulkki K, et al. Abnormal mitochondria in cultured synovial fibroblasts in rheumatoid and reactive arthritis? Br J Rheumatol. 1988;27 Suppl 2:128-31.
Modica-Napolitano JS, Kulawiec M, et al. Mitochondria and human cancer. Curr Mol Med. 2007 Feb;7(1):121-31.
Gerbitz KD, Gempel K, Brdiczka D. Mitochondria and diabetes. Genetic, biochemical, and clinical implications of the cellular energy circuit. Diabetes. 1996 Feb;45(2):113-26.
Biskup S, Moore DJ. Detrimental deletions: mitochondria, aging and Parkinson’s disease. Bioessays. 2006 Oct;28(10):963-7.
Moreira PI, Cardoso SM, et al. The key role of mitochondria in Alzheimer’s disease. J Alzheimers Dis. 2006 Jul;9(2):101-10.
Tsutsui H. Oxidative stress in heart failure: the role of mitochondria. Intern Med. 2001 Dec;40(12):1177-82.
Marin-Garcia J, Goldenthal MJ. Heart mitochondria signaling pathways: appraisal of an emerging field. J Mol Med. 2004 Sep;82(9):565-78